Inventor
MILES DILLON HARDING
US15 patents
Patents
15 patentsUS11001603B2May 11, 2021
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC13 citations93
US10239912B2Mar 26, 2019
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC23 citations93
US10981944B2Apr 20, 2021
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC11 citations84
US11667662B2Jun 6, 2023
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC4 citations83
US11819512B2Nov 21, 2023
Solid forms of a CD73 inhibitor and the use thereof
ARCUS BIOSCIENCES INC5 citations72
US11058704B2Jul 13, 2021
Inhibitors of adenosine 5′-nucleotidase
ARCUS BIOSCIENCES INC4 citations71
US12168023B2Dec 17, 2024
Inhibitors of adenosine 5′-nucleotidase
ARCUS BIOSCIENCES INC1 citations61
US11993584B2May 28, 2024
Solid forms of an azolopyrimidine compound
ARCUS BIOSCIENCES INC0 citations61
US11267845B2Mar 8, 2022
Inhibitors of CD73-mediated immunosuppression
ARCUS BIOSCIENCES INC1 citations61
US11045472B2Jun 29, 2021
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC1 citations61
US12459967B2Nov 4, 2025
Modulators of 5′-nucleotidase, ecto and the use thereof
ARCUS BIOSCIENCES INC0 citations60
US12195482B1Jan 14, 2025
Compounds as inhibitors of AXL
ARCUS BIOSCIENCES INC0 citations55
US11220492B2Jan 11, 2022
Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
ARCUS BIOSCIENCES INC0 citations51
US12410170B2Sep 9, 2025
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
ARCUS BIOSCIENCES INC0 citations48
US12064433B2Aug 20, 2024
Pyridone A2R antagonists
ARCUS BIOSCIENCES INC0 citations47